International Journal of Inflammation / 2019 / Article / Tab 2 / Clinical Study
The Effect of Submucosal Injection of Plasma-Rich Platelets on Blood Inflammatory Markers for Patients with Bimaxillary Protrusion Undergoing Orthodontic Treatment Table 2 Comparison of blood parameters before and after 24 hours and 7 days following PRP injection.
Blood markers Normal level Time No. Mean SD F -ratio value1 WBC 4.0–10.0 109 /L Tb0 18 7.578 2.47 0.01746 0.98 Tb1 7.7 1.79 Tb7 7.633 1.47 2 LYM 1.0–3.5 109 /L Tb0 18 2.161 0.73 0.297 0.743 Tb1 2.32 0.59 Tb7 2.267 1.5 3 LYM% 2.0–45.0% Tb0 18 30.7 8.9 0.0209 0.979 Tb1 31.1 6.65 Tb7 30.7 6.6 4 MID 0.2–1.0 109 /L Tb0 18 0.47 0.2 0.199 0.819 Tb1 0.43 0.08 Tb7 0.44 0.1 5 MID% 2.0–10.0% Tb0 18 6.84 1.42 0.1019 0.903 Tb1 4.96 1.21 Tb7 61.5 1.09 6 GRA 2.5–8.0 109 /L Tb0 18 4.96 2.02 0.0007 0.999 Tb1 4.94 1.5 Tb7 4.93 1.36 7 GRA% 40–80% Tb0 18 61.5 10.05 0.066 0.936 Tb1 62.2 7.25 Tb7 62.5 6.99 8 RBC 4.5–5.50 1012 /L Tb0 18 4.56 0.42 0.282 0.75 Tb1 4.62 0.4 Tb7 4.66 0.38 9 HGB 13.0–17.0 g/dl Tb0 18 12.7 1.5 0.03 0.963 Tb1 12.7 1.57 Tb7 12.8 1.87 10 HCT 40–50% Tb0 18 38.6 3.9 0.0037 0.996 Tb1 38.5 4.29 Tb7 38.5 5.07 11 MCV 80–100 fl Tb0 18 85 8.2 0.144 0.865 Tb1 83.7 9.4 Tb7 83.5 9.3 12 MCH 27–32 pg Tb0 18 28 3.09 0.077 0.925 Tb1 27.7 3.32 Tb7 28 3.46 13 MCHC 31–35 g/dl Tb0 18 32.9 1.03 0.99 0.378 Tb1 33 0.095 Tb7 33.4 1.44 14 RDWa 30–150 fl Tb0 18 44.4 17.3 3.17 0.50 Tb1 52.7 6.48 Tb7 52.4 6.44 15 RDWa% 11–16% Tb0 18 13 1.53 0.027 0.972 Tb1 13.1 0.89 Tb7 13.1 1.01 16 PLT 100–400 109 /L Tb0 18 235 66.9 0.038 0.962 Tb1 240 59.6 Tb7 234 49.6 17 MPV 7.0–11.0 fl Tb0 18 9.24 0.73 0.178 0.837 Tb1 9.12 0.87 Tb7 9.14 0.63 18 PDWa 0.1–99.9 fl Tb0 18 21.3 18.1 4.33 0.018 Tb1 12.3 1.22 Tb7 12.4 0.84 19 PCT 0.01–9.99% Tb0 18 0.21 0.07 0.17 0.84 Tb1 0.22 0.05 Tb7 0.23 0.06 20 P-LCR 0.1–99.9% Tb0 18 22.7 5.53 0.134 0.874 Tb1 22 6.32 Tb7 22.8 4.59 21 B. urea 16–48 mg/dl Tb0 18 20.3 6.1 0.41 0.66 Tb1 22.4 6.88 Tb7 21.3 7.81 22 S. creatinine 0.6–1.3 mg/dl Tb0 18 0.7 0.1 1.81 0.172 Tb1 0.64 0.12 Tb7 0.63 0.12 23 ALK. phosphate 20–140 IU/L Tb0 18 56.3 11.7 4.74 0.013 Tb1 49.1 7.98 Tb7 58.7 9.01 24 GOT (AST) <32 IU/L Tb0 18 18.2 2.32 2.03 0.14 Tb1 21 6.21 Tb7 19.1 3.02 25 GPT (ALT) <30 IU/L Tb0 18 13.8 2.65 1.96 0.15 Tb1 17.6 5.66 Tb7 17.9 10.2 26 Gamma GT (GGT) 0–30 IU/L Tb0 18 13.1 3.71 19.85 0.00001 Tb1 22.1 7.19 Tb7 23.8 4.92 27 S. albumin 3.5–5.2 g/dl Tb0 18 4.48 0.6 6.33 0.0035 Tb1 3.98 0.42 Tb7 4.01 0.36 28 S. total protein 6.4–8.3 g/dl Tb0 18 7.08 0.78 20.66 0.00001 Tb1 9.44 0.8 Tb7 9.02 1.7 29 Total calcium 8.6–10.2 mg/dl Tb0 18 9.3 0.58 3.21 0.049 Tb1 9.59 0.34 Tb7 9.65 0.35 30 Potassium (K) 3.5–5.1 mmol/L Tb0 18 4.14 0.46 1.47 0.239 Tb1 3.98 0.35 Tb7 4.2 0.35 31 Sodium (Na) 136–145 mmol/L Tb0 18 140 3.43 0.179 0.836 Tb1 140 2.22 Tb7 140 5.64 32 Chloride (Cl) 95–115 mmol/L Tb0 18 112 4.25 0.077 0.925 Tb1 112 3.29 Tb7 112 5.01 33 C-reactive protein (CRP) <6.0 mg/L Tb0 2.08 2.58 0.088 0.915 Tb1 2.44 3.19 Tb7 2.38 2.29